Differentiating drugs by harm potential: The rational versus the feasible

Substance Use and Misuse

Volumn 34, Issue 1, 1999, Pages 25-34

  Kalant, Harold ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Harm reduction; Policy; Public health

Indexed keywords

ALCOHOL; CANNABIS; OPIATE DERIVATIVE;

ATTITUDE; DRUG ABUSE; DRUG COST; DRUG LEGISLATION; DRUG MECHANISM; HEALTH CARE POLICY; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; TOBACCO;

EID: 0032909367     PISSN: 10826084     EISSN: None     Source Type: Journal    
DOI: 10.3109/10826089909035633     Document Type: Review

References (29)

1. BACHMAN, J., JOHNSTON, L., O'MALLEY, P., and HUMPHREY, R. (1988). Explaining the recent decline in marijuana use: Differentiating the effects of perceived risks, disapproval, and general lifestyle factors. J. Health Soc. Behav. 29: 92-112.
2. BENOWITZ, N. L. (1992). How toxic is cocaine? In G. R. Bock and J. Whelan (Eds.), Cocaine: Scientific and Social Dimensions (Ciba Foundation Symposium No. 166). Chichester: Wiley Interscience, pp. 125-148.
3. CUSHMAN, P. (1980). The major medical sequelae of opioid addiction. Drug Alcohol Depend 5: 239-254.
4. DRESSLER, F. A., and ROBERTS, W. C. (1989). Infective endocarditis in opiate addicts: Analysis of 80 cases studied at necropsy. Am. J. Cardiol. 63: 1240-1257.
5. FIBIGER, H. C., PHILLIPS, A. G., and BROWN, E. E. (1992). The neurobiology of cocaine-induced reinforcement. In G. R. Bock and J. Whelan (Eds.), Cocaine: Scientific and Social Dimensions (Ciba Foundation Symposium No. 166). Chichester: Wiley Interscience, pp. 96-111.
6. FINNEGAN, L. P. (1985). Effects of maternal opiate abuse on the newborn. Fed. Proc. 44:2314-2317.
7. FOLEY, K. M. (1993). Opioids. Neurol. Clin. 11: 503-522.
8. GARDNER, E. L., and LOWINSON, J. H. (1991). Marijuana's interaction with brain reward systems: Update 1991. Pharmacol., Biochem. Behav. 40: 571-580.
9. GOLDSTEIN, A. (1994) Addiction: From Biology to Drug Policy. New York, NY: Freeman.
10. GOLDSTEIN, A., and KALANT, H. (1990). Drug policy: Striking the right balance. Science 249: 1513-1521.
11. HALL, W., SOLOWIJ, N., and LEMON, J. (1994). The Health and Psychological Consequences of Cannabis Use (A report prepared for the Australian National Task Force on Cannabis). Sydney, NSW: National Drug and Alcohol Research Centre.
12. HARRIS, R. A., BRODIE, M. S., and DUNWIDDIE, T. V. (1992). Possible substrates of ethanol reinforcement: GABA and dopamine. Ann. N. Y. Acad. Sci. 654: 61-69.
13. HOLLISTER, L. E. (1986). Health aspects of cannabis. Pharmacol. Rev. 38: 1-20.
14. KALANT, H. (1989). The nature of addiction: An analysis of the problem. In A. Goldstein (Ed.), Molecular and Cellular Aspects of the Drug Addictions (pp. 1-28). New York, NY: Springer-Verlag.
15. KOOB, G. F. (1992). Neural mechanisms of drug reinforcement. Ann. N. Y. Acad. Sci. 654: 171-191.
16. KORNETSKY, C., and PORRINO, L. J. (1992). Brain mechanisms of drug-induced reinforcement. Res. Publ. - Assoc. Res. Nerv. Ment. Dis. 70: 59-77.
17. LEVINE, D. P., CRANE, L. R., and ZERVOS, M. J. (1986). Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: A prospective comparative study. Rev. Infect. Dis. 8: 374-396.
18. NIAAA (1994). Alcohol and Health: Eighth Special Report to the US Congress. Washington, DC: US Department of Health and Human Services.
19. OTTOMANELLI, G. (1993). Risk dimensions of HIV-tested substance users. Int. J. Addict. 28: 1487-1495.
20. POPHAM, R. E., SCHMIDT, W., and DE LINT, J. (1975). The prevention of alcoholism: Epidemiological studies of the effects of government control measures. Br. J. Addict. 70: 125-144.
21. POPHAM, R. E., SCHMIDT, W., and ISRAELSTAM, S. (1984). Heavy alcohol consumption and physical health problems. In R. G. Smart et al. (Eds.), Research Advances in Alcohol and Drug Problems. Vol. 8 (pp. 149-182). New York, NY: Plenum.
22. RUSSELL, M. A. H. (1973). Changes in cigarette price and consumption by men in Britain, 1946-71: A preliminary analysis. Br. J. Prev. Soc. Med. 27: 1-7.
23. SCHMIDT, W. (1977). The epidemiology of cirrhosis of the liver: A statistical analysis of mortality data with special reference to Canada. In M. M. Fisher and J. G. Rankin (Eds.), Alcohol and the Liver (pp. 1-26). New York, NY: Plenum.
24. SINGLE, E., WILLIAMS, B., and McKENZIE, D. (Eds.) (1994). Canadian Profile: Alcohol, Tobacco & Other Drugs, 1994. Ottawa and Toronto: Canadian Centre on Substance Abuse and Addiction Research Foundation.
25. SKOG, O.-J. (1986). The long waves of alcohol consumption: A social network perspective on cultural change. Soc. Networks 8: 1-32.
26. SMART, R. G. (1992). Drug education programs for young people. In J. White (Ed.), Drug Problems in Society - Dimensions and Perspectives (pp. 178-183). Parkside, S. Australia: Drug and Alcohol Services Council.
27. SURGEON GENERAL (1979). In Office of Smoking and Health (Ed.), Smoking and Health. Washington, DC: US Government Printing Office.
28. WISE, R. A. (1989). The brain and reward. In J. M. Liebman and S. J. Cooper (Eds.), The Neuropharmacological Basis of Reward (pp. 377-424). Oxford: Oxford University Press.
29. ZIMMERMAN, H. J., and MADDREY, W. C. (1987). Toxic and drug-induced hepatitis. In L. Schiff and E. R. Schiff (Eds.), Diseases of the Liver, 5th ed. (pp. 591-667). Philadelphia, PA: Lippincott.